Hapvida (HAPV3) announced on Wednesday, November 11, 2026, that its subsidiary Hapvida Assistência Médica has entered into a purchase and sale agreement with Fundação Educacional Lucas Machado (FELUMA) for the properties where the Octaviano Neves Hospital operates, in Belo Horizonte (MG). The total price is R$ 60 million.

Of that amount, 20% was paid as a down payment at signing. The remaining balance will be paid at closing of the transaction, expected in early 2027, after the hospital operations at the properties have been fully wound down.

The transaction includes only the properties and is part of the company's asset optimization strategy, which may involve other steps to be announced to the market.

Patient care at the Octaviano Neves Hospital is being transferred, gradually and as planned, to Hapvida's own network in Belo Horizonte. According to the company, the move preserves the continuity and quality of care for members in the region.

Source: Notice to the Market, filed with the CVM on 11/11/2026 19:56. View original document

For information only; not investment advice.

Is HAPV3 worth investing in?

HAPV3Hapvida · B3
Price
R$ 4.25
as of 11/10/2026
Dividend yield
0.00 %
P/L
N/A
P/VPA
0.04
View full analysis of HAPV3